Detection of HIV ‐1 Antibodies in Saliva of Persons Living With HIV Using Blood‐Based First Response HIV 1‐2.O Card Test
Journal of Clinical Laboratory Analysis · 2025
DOI: 10.1002/jcla.70069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2025. Verfasst von Enoch Aninagyei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Basic and Biomedical Sciences, University of Health and Allied Sciences, Ho, Volta Region, Ghana. Hauptthemen laut MEDLINE: Saliva, HIV Infections, HIV Antibodies, HIV-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study tested HIV‐1 antibodies in saliva samples (sHIV‐1 Ab) collected by the Self‐Lollisponge device.
Methods
Blood and saliva from confirmed persons with HIV and HIV‐negative controls were analyzed for HIV‐1/2 antibodies using the blood‐based First Response HIV 1‐2.O Card Test. The sampling device containing sHIV‐1 Ab was stored at 6°C for 60 days, with intermittent testing on days 2, 5, 10, 20, 30, and 60. Regression analysis was done to assess the relationship between the presence of sHIV‐1 Ab and independent variables.
Results
The sensitivity and the specificity of detecting sHIV‐1 Ab were 72.9% (95% CI: 63.92%–80.65%) and 100% (95% CI: 92.89%–100.00%), respectively. The presence of opportunistic infections (AOR = 13.1, p < 0.001), having stomatorrhagia (AOR = 4.56, p = 0.0022), and hyperviremia (> 201 copies/mL) (AOR = 4.91, p = 0.0225) heightened sHIV‐1 Ab detection. Furthermore, fatigue (AOR = 12.1, p = 0.0024), fever (AOR = 3.5, p = 0.0144), and weight loss (AOR = 10.9, p = 0.0318) increased the odds of having sHIV‐1 Ab in persons living with HIV (PLWHIV). sHIV‐1 Ab was identified in over 90% of PLWHIV with opportunistic infections (OIs) and stomatorrhagia, OIs and hyperviremia, and stomatorrhagia and hyperviremia. Upon storage for 60 days, the sHIV‐1 Ab was detected in all the samples.
Conclusion
Saliva could be an alternative to blood for diagnosing HIV. In addition, the Self‐Lollisponge device was found to be user‐friendly, acquiescent to all settings, and cheap, and can preserve sHIV‐1 Ab for at least 60 days.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, School of Basic and Biomedical Sciences, University of Health and Allied Sciences, Ho, Volta Region, Ghana.
- Department of Biomedical Sciences, School of Allied Health Sciences, University of Cape Coast, Ghana.
- Laboratory Department, Catholic Hospital, Anfoega, Catholic Health Service Trust- Ho Diocese, Volta Region, Ghana.
ORCID-Profile: Enoch Aninagyei, Godknows Afenya
Zitieren
APA
Aninagyei, E., Boatey, C. A., Larbi, G., Tsidi, W. B., Amemo, R. E., Nyarkotey, E. T., Afenya, G., & Acheampong, D. O. (2025). Detection of HIV ‐1 Antibodies in Saliva of Persons Living With HIV Using Blood‐Based First Response HIV 1‐2.O Card Test. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70069
Vancouver
Aninagyei E, Boatey CA, Larbi G, Tsidi WB, Amemo RE, Nyarkotey ET, et al. Detection of HIV ‐1 Antibodies in Saliva of Persons Living With HIV Using Blood‐Based First Response HIV 1‐2.O Card Test. Journal of Clinical Laboratory Analysis. 2025. doi:10.1002/jcla.70069
BibTeX
@article{Aninagyei2025,
author = {Aninagyei, Enoch and Boatey, Comfort Addo and Larbi, Gifty and Tsidi, Wilson Bright and Amemo, Raphael Eyram and Nyarkotey, Ebenezer Tawiah and Afenya, Godknows and Acheampong, Desmond Omane},
title = {Detection of HIV ‐1 Antibodies in Saliva of Persons Living With HIV Using Blood‐Based First Response HIV 1‐2.O Card Test},
journal = {Journal of Clinical Laboratory Analysis},
year = {2025},
doi = {10.1002/jcla.70069}
}
EUVIMED